Health Trials

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

ConditionsMitochondrial DisordersMitochondrial Genetic DisordersMitochondrial DiseasesDisorder of Mitochondrial Respiratory Chain ComplexesDeletion and Duplication of Mitochondrial DNA
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorColumbia University

About this trial

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Eligibility criteria

Qualifiers

Patients diagnosed with or suspected to have a mitochondrial disorder

Adult carriers of known mitochondrial DNA mutations

Patients with laboratory analysis indicative of a mitochondrial disorder.

Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.

Disqualifiers

Patients not suspected of having a mitochondrial disorder

Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Columbia University

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Source ClinicalTrials.gov